In last trading session, Vir Biotechnology Inc (NASDAQ:VIR) saw 1.23 million shares changing hands with its beta currently measuring 1.22. Company’s recent per share price level of $4.55 trading at $0.05 or 1.11% at ring of the bell on the day assigns it a market valuation of $628.98M. That closing price of VIR’s stock is at a discount of -217.58% from its 52-week high price of $14.45 and is indicating a premium of 4.4% from its 52-week low price of $4.35.
For Vir Biotechnology Inc (VIR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.56. Splitting up the data highlights that, out of 10 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Vir Biotechnology Inc (NASDAQ:VIR) trade information
Upright in the green during last session for gaining 1.11%, in the last five days VIR remained trading in the red while hitting it’s week-highest on Monday, 05/12/25 when the stock touched $4.55 price level, adding 18.31% to its value on the day. Vir Biotechnology Inc’s shares saw a change of -38.01% in year-to-date performance and have moved -15.90% in past 5-day. Vir Biotechnology Inc (NASDAQ:VIR) showed a performance of -19.04% in past 30-days.
Wall Street analysts have assigned a consensus price target of 20 to the stock, which implies a rise of 77.25% to its current value. Analysts have been projecting 20 as a low price target for the stock while placing it at a high target of 20. It follows that stock’s current price would drop -339.56% in reaching the projected high whereas dropping to the targeted low would mean a loss of -339.56% for stock’s current value.
Vir Biotechnology Inc (VIR) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -18.74% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 13.97% while estimates for its earnings growth in next 5 years are of 8.97%.
Vir Biotechnology Inc (NASDAQ:VIR)’s Major holders
SB INVESTMENT ADVISERS (UK) LTD is the top institutional holder at VIR for having 16.68 million shares of worth $148.49 million. And as of 2024-06-30, it was holding 12.2466 of the company’s outstanding shares.
The second largest institutional holder is BLACKROCK INC., which was holding about 16.43 million shares on 2024-06-30. The number of shares represents firm’s hold over 12.0632 of outstanding shares, having a total worth of $146.26 million.
On the other hand, iShares Trust-iShares Core S&P Small-Cap ETF and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 5.82 shares of worth $26.47 million or 4.21% of the total outstanding shares. The later fund manager was in possession of 3.44 shares on Dec 31, 2024, making its stake of worth around $15.65 million in the company or a holder of 2.49% of company’s stock.
